Offline mode

Anti-Human RIG-I (CTD) Rabbit IgG

Catalog no.JP28137
Quantity / Tests
50 µg
Species / Antigen
human, mouse
Host
rabbit
Subclass / Clone
IgG
Type
Polyclonal
Purification
with Antigen Peptide
Regulatory Status
RUO

This antibody was raised against the c-terminal domain of human RIG-I. RIG-I (retinoic acid inducible gene-I) is a cytoplasmic viral sensor, that has a RNA helicase domain and it is believed to recognize virus-derived double-stranded RNA (dsRNA). It is considered that RIG-I normally exists as an inactive form in the cytoplasm and turns to an active form when it recognizes dsRNA produced as a by-product of viral replication. It is thought that the active form of RIG-I exposes a signaling domain called CARD (caspase recruitment domain) which is normally hidden by steric hindrance. Downstream signaling then is activated by multimerization and interaction of CARD with IPS-1 expressed on mitochondria, eventually inducing the activation of interferon gene. Thus, RIG-I is believed to play an important role in viral infection-induced signaling. This antibody recognizes CTD (C terminal domain) of RIG-I and is able to detect RIG-I localized in avSGs (antiviral stress granules) that are genesis-induced in virus-infected cells. Distributed by IBL International

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.